Posttranslational regulation of Fas ligand function
Open Access
- 29 December 2008
- journal article
- Published by Springer Science and Business Media LLC in Cell Communication and Signaling
- Vol. 6 (1), 11
- https://doi.org/10.1186/1478-811x-6-11
Abstract
The TNF superfamily member Fas ligand acts as a prototypic death factor. Due to its ability to induce apoptosis in Fas (APO-1, CD95) expressing cells, Fas ligand participates in essential effector functions of the immune system. It is involved in natural killer cell- and T cell-mediated cytotoxicity, the establishment of immune privilege, and in termination of immune responses by induction of activation-induced cell death. In addition, Fas ligand-positive tumours may evade immune surveillance by killing Fas-positive tumour-infiltrating cells. Given these strong cytotoxic capabilities of Fas ligand, it is obvious that its function has to be strictly regulated to avoid uncontrolled damage. In hematopoietic cells, the death factor is stored in secretory lysosomes and is mobilised to the immunological synapse only upon activation. The selective sorting to and the release from this specific lysosomal compartment requires interactions of the Fas ligand cytosolic moiety, which mediates binding to various adapter proteins involved in trafficking and cytoskeletal reorganisation. In addition, Fas ligand surface expression is further regulated by posttranslational ectodomain shedding and subsequent regulated intramembrane proteolysis, releasing a soluble ectodomain cytokine into the extracellular space and an N-terminal fragment with a potential role in intracellular signalling processes. Moreover, other posttranslational modifications of the cytosolic domain, including phosphorylation and ubiquitylation, have been described to affect various aspects of Fas ligand biology. Since FasL is regarded as a potential target for immunotherapy, the further characterisation of its biological regulation and function will be of great importance for the development and evaluation of future therapeutic strategies.Keywords
This publication has 96 references indexed in Scilit:
- The adaptor protein Grb2 regulates cell surface Fas ligand in Schwann cellsBiochemical and Biophysical Research Communications, 2008
- Identification of interaction partners for individual SH3 domains of Fas ligand associated members of the PCH protein family in T lymphocytesBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2008
- Plasminogen Activator Inhibitor-1 Protects Endothelial Cells from FasL-Mediated ApoptosisCancer Cell, 2008
- The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cellsCell Death & Differentiation, 2007
- A γ-secretase-like intramembrane cleavage of TNFα by the GxGD aspartyl protease SPPL2bNature, 2006
- SPPL2a and SPPL2b promote intramembrane proteolysis of TNFα in activated dendritic cells to trigger IL-12 productionNature, 2006
- The adaptor protein Nck interacts with Fas ligand: Guiding the death factor to the cytotoxic immunological synapseProceedings of the National Academy of Sciences of the United States of America, 2006
- Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transductionBiochemical Journal, 2005
- PACSIN3 Binds ADAM12/Meltrin α and Up-regulates Ectodomain Shedding of Heparin-binding Epidermal Growth Factor-like Growth FactorPublished by Elsevier BV ,2003
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993